Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credits™.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669.
PER’s practice changing 4th Annual School of Gastrointestinal Oncology® (SOGO™®) is a 1-day multidisciplinary educational conference, revolutionizing the presentation of emerging therapies and evolving standards of care in the management of patients with gastrointestinal (GI) tumors in the context of the program theme, to individualize care.
GI cancers are some of them most complex solid tumors to treat because of their heterogeneity. Optimized management requires a high level of multidisciplinary cooperation. The rapid pace of emerging developments creates knowledge and competence gaps for you and your colleagues who treat, manage, and care for patients with GI cancers.
Led by world-renowned experts John L. Marshall, MD, and Michael A. Choti, MD, MBA, FACS, this multi-track symposium, now in its fourth year, will provide you with the tools you need to personalize care for every patient with GI cancer you treat. The program will include various modules that feature general session presentations on key learning concepts, along with separate side tracks to provide a workshop sensibility to personalize learning in smaller and more intimate settings. With 3 tracks–medical oncology, surgical and radiation oncology, and multidisciplinary management and communication—the program is designed to match your learning interests.
This year’s symposium will once again feature the dynamic and interactive Medical Crossfire® format, where experts will engage in a rigorous debate to answer your questions, and reach consensus on ongoing paradigm shifts. The program will focus on the latest data on prognostic and predictive markers that impact clinical decision making, current and emerging treatment strategies, and case-based lectures by expert faculty who will focus on the practical application of knowledge to the complex care scenarios encountered in contemporary practice settings. Physicians’ Education Resource® (PER®) will continue to use its proven educational modalities to ensure a highly interactive meeting that fosters discussion and exchange of ideas, best practices, and cross-team cooperation in the clinic. This will include case-based tumor boards, question-and-answer sessions, ARS polling, and networking opportunities.
“The evolution of treating patients who have gastrointestinal (GI) cancers has really transformed over the past few years and will continue to do so moving forward. We know that personalizing disease in these tumors has to be done, and we need to involve the entire clinical team to do so. The expanded role of immune therapies, the importance of multidisciplinary care, and the role of precision medicine has further complicated the pathways of care. With all the advances that have been made in both treatment and care management, we have turned GI cancer into a chess game, and we need to make sure all the players and pieces are working together. This meeting will continue to education the treatment team through multiple presentations and small group discussions and will truly be the most unique GI cancers meeting around.”
— John Marshall, MD
Ruesch Center for the Cure of GI Cancers
Georgetown University Medical Center
ONS: PER Forum™: Nursing Opportunities to Improve Outcomes With the Advent of PARP Inhibitors in the Care of Women’s Cancers
May 17, 2018
ONS: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for Nurses
May 17, 2018
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of Cancers
May 30, 2018
May 31, 2018
May 31, 2018